| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyBiologicalProcess | skin epidermis development | 6.29e-06 | 166 | 33 | 5 | GO:0098773 | |
| GeneOntologyBiologicalProcess | establishment of skin barrier | 3.82e-05 | 41 | 33 | 3 | GO:0061436 | |
| GeneOntologyBiologicalProcess | regulation of metanephric nephron tubule epithelial cell differentiation | 5.19e-05 | 7 | 33 | 2 | GO:0072307 | |
| GeneOntologyBiologicalProcess | metanephric nephron tubule epithelial cell differentiation | 5.19e-05 | 7 | 33 | 2 | GO:0072257 | |
| GeneOntologyBiologicalProcess | epidermis development | 8.01e-05 | 461 | 33 | 6 | GO:0008544 | |
| GeneOntologyBiologicalProcess | regulation of nephron tubule epithelial cell differentiation | 1.91e-04 | 13 | 33 | 2 | GO:0072182 | |
| GeneOntologyBiologicalProcess | positive regulation of nuclear-transcribed mRNA poly(A) tail shortening | 2.23e-04 | 14 | 33 | 2 | GO:0060213 | |
| GeneOntologyBiologicalProcess | nephron tubule epithelial cell differentiation | 2.57e-04 | 15 | 33 | 2 | GO:0072160 | |
| GeneOntologyBiologicalProcess | regulation of nuclear-transcribed mRNA poly(A) tail shortening | 2.94e-04 | 16 | 33 | 2 | GO:0060211 | |
| GeneOntologyBiologicalProcess | skin development | 2.95e-04 | 373 | 33 | 5 | GO:0043588 | |
| GeneOntologyBiologicalProcess | external encapsulating structure organization | 3.17e-04 | 379 | 33 | 5 | GO:0045229 | |
| GeneOntologyBiologicalProcess | neuron development | 3.60e-04 | 1463 | 33 | 9 | GO:0048666 | |
| GeneOntologyBiologicalProcess | regulation of neuron projection development | 3.72e-04 | 612 | 33 | 6 | GO:0010975 | |
| GeneOntologyBiologicalProcess | regulation of epithelial cell differentiation involved in kidney development | 4.17e-04 | 19 | 33 | 2 | GO:2000696 | |
| GeneOntologyBiologicalProcess | metanephric nephron tubule development | 5.11e-04 | 21 | 33 | 2 | GO:0072234 | |
| GeneOntologyBiologicalProcess | cell differentiation involved in metanephros development | 5.62e-04 | 22 | 33 | 2 | GO:0072202 | |
| GeneOntologyBiologicalProcess | metanephric nephron epithelium development | 6.15e-04 | 23 | 33 | 2 | GO:0072243 | |
| GeneOntologyBiologicalProcess | neuron projection development | 7.59e-04 | 1285 | 33 | 8 | GO:0031175 | |
| GeneOntologyBiologicalProcess | metanephric tubule development | 7.88e-04 | 26 | 33 | 2 | GO:0072170 | |
| GeneOntologyBiologicalProcess | metanephric epithelium development | 9.14e-04 | 28 | 33 | 2 | GO:0072207 | |
| GeneOntologyBiologicalProcess | forebrain development | 1.01e-03 | 489 | 33 | 5 | GO:0030900 | |
| GeneOntologyCellularComponent | keratohyalin granule | 3.58e-08 | 5 | 33 | 3 | GO:0036457 | |
| GeneOntologyCellularComponent | cornified envelope | 4.14e-06 | 69 | 33 | 4 | GO:0001533 | |
| GeneOntologyCellularComponent | desmosome | 8.90e-04 | 28 | 33 | 2 | GO:0030057 | |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | 1.36e-03 | 530 | 33 | 5 | GO:0062023 | |
| Domain | Filaggrin | 3.03e-06 | 2 | 33 | 2 | IPR003303 | |
| Domain | Ago_hook | 9.07e-06 | 3 | 33 | 2 | PF10427 | |
| Domain | TNRC6-PABC_bdg | 9.07e-06 | 3 | 33 | 2 | PF16608 | |
| Domain | TNRC6_PABC-bd | 9.07e-06 | 3 | 33 | 2 | IPR032226 | |
| Domain | Argonaute_hook_dom | 9.07e-06 | 3 | 33 | 2 | IPR019486 | |
| Domain | S100_CABP | 1.43e-05 | 27 | 33 | 3 | PS00303 | |
| Domain | S_100 | 1.43e-05 | 27 | 33 | 3 | PF01023 | |
| Domain | S100_Ca-bd_sub | 1.60e-05 | 28 | 33 | 3 | IPR013787 | |
| Domain | S100/CaBP-9k_CS | 1.60e-05 | 28 | 33 | 3 | IPR001751 | |
| Domain | S_100 | 1.60e-05 | 28 | 33 | 3 | SM01394 | |
| Domain | EF_Hand_1_Ca_BS | 3.59e-03 | 175 | 33 | 3 | IPR018247 | |
| Domain | EF_HAND_1 | 5.50e-03 | 204 | 33 | 3 | PS00018 | |
| Domain | UBA-like | 5.70e-03 | 64 | 33 | 2 | IPR009060 | |
| Domain | RhoGEF | 6.41e-03 | 68 | 33 | 2 | SM00325 | |
| Domain | DH_2 | 6.78e-03 | 70 | 33 | 2 | PS50010 | |
| Domain | RhoGEF | 6.78e-03 | 70 | 33 | 2 | PF00621 | |
| Domain | DH-domain | 6.97e-03 | 71 | 33 | 2 | IPR000219 | |
| Domain | - | 6.97e-03 | 71 | 33 | 2 | 1.20.900.10 | |
| Domain | PH | 7.57e-03 | 229 | 33 | 3 | PF00169 | |
| Domain | RRM | 7.66e-03 | 230 | 33 | 3 | PS50102 | |
| Domain | EF_HAND_2 | 7.75e-03 | 231 | 33 | 3 | PS50222 | |
| Domain | - | 7.77e-03 | 449 | 33 | 4 | 3.30.40.10 | |
| Domain | EF_hand_dom | 7.84e-03 | 232 | 33 | 3 | IPR002048 | |
| Domain | Znf_RING/FYVE/PHD | 8.38e-03 | 459 | 33 | 4 | IPR013083 | |
| Domain | - | 9.00e-03 | 244 | 33 | 3 | 3.30.70.330 | |
| Domain | Nucleotide-bd_a/b_plait | 1.05e-02 | 258 | 33 | 3 | IPR012677 | |
| Domain | - | 1.08e-02 | 261 | 33 | 3 | 1.10.238.10 | |
| Domain | PH | 1.28e-02 | 278 | 33 | 3 | SM00233 | |
| Domain | PH_DOMAIN | 1.29e-02 | 279 | 33 | 3 | PS50003 | |
| Domain | PH_domain | 1.31e-02 | 280 | 33 | 3 | IPR001849 | |
| Domain | EF-hand-dom_pair | 1.39e-02 | 287 | 33 | 3 | IPR011992 | |
| Pathway | REACTOME_POST_TRANSCRIPTIONAL_SILENCING_BY_SMALL_RNAS | 4.88e-05 | 6 | 26 | 2 | MM15083 | |
| Pathway | REACTOME_POST_TRANSCRIPTIONAL_SILENCING_BY_SMALL_RNAS | 6.83e-05 | 7 | 26 | 2 | M46421 | |
| Pathway | REACTOME_REGULATION_OF_PTEN_MRNA_TRANSLATION | 1.17e-04 | 9 | 26 | 2 | M27810 | |
| Pathway | REACTOME_REGULATION_OF_NPAS4_MRNA_TRANSLATION | 1.17e-04 | 9 | 26 | 2 | M46436 | |
| Pathway | REACTOME_REGULATION_OF_CDH11_MRNA_TRANSLATION_BY_MICRORNAS | 1.46e-04 | 10 | 26 | 2 | M48013 | |
| Pathway | REACTOME_REGULATION_OF_NPAS4_GENE_EXPRESSION | 2.52e-04 | 13 | 26 | 2 | M46434 | |
| Pathway | REACTOME_REGULATION_OF_RUNX1_EXPRESSION_AND_ACTIVITY | 4.37e-04 | 17 | 26 | 2 | M27788 | |
| Pathway | REACTOME_REGULATION_OF_MITF_M_DEPENDENT_GENES_INVOLVED_IN_APOPTOSIS | 5.49e-04 | 19 | 26 | 2 | M48238 | |
| Pathway | REACTOME_TGFBR3_EXPRESSION | 1.20e-03 | 28 | 26 | 2 | M48253 | |
| Pathway | REACTOME_CELL_JUNCTION_ORGANIZATION | 1.26e-03 | 117 | 26 | 3 | M19248 | |
| Pathway | REACTOME_RUNX2_REGULATES_BONE_DEVELOPMENT | 1.47e-03 | 31 | 26 | 2 | M27805 | |
| Pathway | REACTOME_REGULATION_OF_HOMOTYPIC_CELL_CELL_ADHESION | 1.57e-03 | 32 | 26 | 2 | M48012 | |
| Pathway | REACTOME_REGULATION_OF_MECP2_EXPRESSION_AND_ACTIVITY | 1.57e-03 | 32 | 26 | 2 | M27900 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_NPAS4 | 1.77e-03 | 34 | 26 | 2 | M46422 | |
| Pathway | REACTOME_ONCOGENE_INDUCED_SENESCENCE | 1.87e-03 | 35 | 26 | 2 | M27190 | |
| Pathway | REACTOME_NR1H3_NR1H2_REGULATE_GENE_EXPRESSION_LINKED_TO_CHOLESTEROL_TRANSPORT_AND_EFFLUX | 2.09e-03 | 37 | 26 | 2 | M29790 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_VENTX | 2.57e-03 | 41 | 26 | 2 | M29748 | |
| Pathway | REACTOME_CELL_CELL_COMMUNICATION | 2.82e-03 | 155 | 26 | 3 | M522 | |
| Pathway | REACTOME_SIGNALING_BY_TGFB_FAMILY_MEMBERS | 3.13e-03 | 161 | 26 | 3 | M27871 | |
| Pathway | REACTOME_NR1H2_AND_NR1H3_MEDIATED_SIGNALING | 3.36e-03 | 47 | 26 | 2 | M29777 | |
| Pathway | REACTOME_GENE_SILENCING_BY_RNA | 3.65e-03 | 49 | 26 | 2 | MM14837 | |
| Pathway | REACTOME_SIGNALING_BY_TGFBR3 | 3.65e-03 | 49 | 26 | 2 | M48250 | |
| Pubmed | Defects of filaggrin-like proteins in both lesional and nonlesional atopic skin. | 7.78e-10 | 3 | 33 | 3 | 23403047 | |
| Pubmed | 5.18e-07 | 1429 | 33 | 10 | 35140242 | ||
| Pubmed | Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer. | 8.26e-07 | 184 | 33 | 5 | 32908313 | |
| Pubmed | 8.73e-07 | 2 | 33 | 2 | 29791863 | ||
| Pubmed | Atopic Dermatitis Susceptibility Variants in Filaggrin Hitchhike Hornerin Selective Sweep. | 8.73e-07 | 2 | 33 | 2 | 27678121 | |
| Pubmed | 8.73e-07 | 2 | 33 | 2 | 24813994 | ||
| Pubmed | Variation in genes of the epidermal differentiation complex in German atopic dermatitis patients. | 1.02e-06 | 21 | 33 | 3 | 19601998 | |
| Pubmed | BioID-based Identification of Skp Cullin F-box (SCF)β-TrCP1/2 E3 Ligase Substrates. | 2.27e-06 | 226 | 33 | 5 | 25900982 | |
| Pubmed | GATA3 regulates FLG and FLG2 expression in human primary keratinocytes. | 2.62e-06 | 3 | 33 | 2 | 28928464 | |
| Pubmed | Impact of scaffolding protein TNRC6 paralogs on gene expression and splicing. | 2.62e-06 | 3 | 33 | 2 | 34108231 | |
| Pubmed | 2.62e-06 | 3 | 33 | 2 | 16880270 | ||
| Pubmed | 2.62e-06 | 3 | 33 | 2 | 32437351 | ||
| Pubmed | 2.62e-06 | 3 | 33 | 2 | 31670606 | ||
| Pubmed | DDX24 promotes metastasis by regulating RPL5 in non-small cell lung cancer. | 2.92e-06 | 238 | 33 | 5 | 35864588 | |
| Pubmed | Two PABPC1-binding sites in GW182 proteins promote miRNA-mediated gene silencing. | 5.23e-06 | 4 | 33 | 2 | 21063388 | |
| Pubmed | 5.72e-06 | 754 | 33 | 7 | 35906200 | ||
| Pubmed | 6.96e-06 | 777 | 33 | 7 | 35844135 | ||
| Pubmed | 8.72e-06 | 5 | 33 | 2 | 30862798 | ||
| Pubmed | SPATA2 Links CYLD to LUBAC, Activates CYLD, and Controls LUBAC Signaling. | 1.27e-05 | 558 | 33 | 6 | 27591049 | |
| Pubmed | 1.31e-05 | 6 | 33 | 2 | 27304082 | ||
| Pubmed | 1.83e-05 | 7 | 33 | 2 | 19383768 | ||
| Pubmed | Functional dissection of the human TNRC6 (GW182-related) family of proteins. | 1.83e-05 | 7 | 33 | 2 | 19470757 | |
| Pubmed | SPATA2-Mediated Binding of CYLD to HOIP Enables CYLD Recruitment to Signaling Complexes. | 1.97e-05 | 353 | 33 | 5 | 27545878 | |
| Pubmed | CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality. | 2.01e-05 | 605 | 33 | 6 | 28977666 | |
| Pubmed | Ubiquitin-Independent Disassembly by a p97 AAA-ATPase Complex Drives PP1 Holoenzyme Formation. | 2.19e-05 | 361 | 33 | 5 | 30344098 | |
| Pubmed | Proteomic characterization of human multiple myeloma bone marrow extracellular matrix. | 2.83e-05 | 62 | 33 | 3 | 28344315 | |
| Pubmed | 2.83e-05 | 62 | 33 | 3 | 26644517 | ||
| Pubmed | 2.87e-05 | 382 | 33 | 5 | 37249651 | ||
| Pubmed | Dchs1-Fat4 regulation of osteogenic differentiation in mouse. | 4.78e-05 | 11 | 33 | 2 | 31358536 | |
| Pubmed | Gene-trap mutagenesis using Mol/MSM-1 embryonic stem cells from MSM/Ms mice. | 4.82e-05 | 74 | 33 | 3 | 23604909 | |
| Pubmed | LncRNA SAMD12-AS1 promotes cell proliferation and inhibits apoptosis by interacting with NPM1. | 5.73e-05 | 12 | 33 | 2 | 31406141 | |
| Pubmed | 7.07e-05 | 1116 | 33 | 7 | 31753913 | ||
| Pubmed | Mammalian miRNA RISC recruits CAF1 and PABP to affect PABP-dependent deadenylation. | 7.89e-05 | 14 | 33 | 2 | 19716330 | |
| Pubmed | PRDM14 directly interacts with heat shock proteins HSP90α and glucose-regulated protein 78. | 7.89e-05 | 14 | 33 | 2 | 29178343 | |
| Pubmed | TRIM25 and DEAD-Box RNA Helicase DDX3X Cooperate to Regulate RIG-I-Mediated Antiviral Immunity. | 8.93e-05 | 91 | 33 | 3 | 34445801 | |
| Pubmed | GW182 proteins directly recruit cytoplasmic deadenylase complexes to miRNA targets. | 9.10e-05 | 15 | 33 | 2 | 21981923 | |
| Pubmed | 1.04e-04 | 16 | 33 | 2 | 31823782 | ||
| Pubmed | 1.05e-04 | 503 | 33 | 5 | 16964243 | ||
| Pubmed | 1.10e-04 | 263 | 33 | 4 | 34702444 | ||
| Pubmed | 1.29e-04 | 103 | 33 | 3 | 10819331 | ||
| Pubmed | 1.32e-04 | 18 | 33 | 2 | 26209645 | ||
| Pubmed | 1.33e-04 | 529 | 33 | 5 | 14621295 | ||
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | 1.42e-04 | 861 | 33 | 6 | 36931259 | |
| Pubmed | 1.44e-04 | 107 | 33 | 3 | 30995489 | ||
| Pubmed | 1.44e-04 | 107 | 33 | 3 | 32989256 | ||
| Pubmed | 1.64e-04 | 20 | 33 | 2 | 26116666 | ||
| Pubmed | E-cadherin interactome complexity and robustness resolved by quantitative proteomics. | 1.81e-04 | 565 | 33 | 5 | 25468996 | |
| Pubmed | 1.99e-04 | 22 | 33 | 2 | 22187428 | ||
| Pubmed | 2.18e-04 | 23 | 33 | 2 | 28811219 | ||
| Pubmed | p63 exerts spatio-temporal control of palatal epithelial cell fate to prevent cleft palate. | 2.38e-04 | 24 | 33 | 2 | 28604778 | |
| Pubmed | Stromal-epithelial crosstalk regulates kidney progenitor cell differentiation. | 2.80e-04 | 26 | 33 | 2 | 23974041 | |
| Pubmed | αE-Catenin Is a Positive Regulator of Pancreatic Islet Cell Lineage Differentiation. | 2.80e-04 | 26 | 33 | 2 | 28793255 | |
| Pubmed | E3 Ligase Trim21 Ubiquitylates and Stabilizes Keratin 17 to Induce STAT3 Activation in Psoriasis. | 2.87e-04 | 135 | 33 | 3 | 29859926 | |
| Pubmed | 3.02e-04 | 27 | 33 | 2 | 26544073 | ||
| Pubmed | 3.14e-04 | 346 | 33 | 4 | 25324306 | ||
| Pubmed | ∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis. | 3.38e-04 | 647 | 33 | 5 | 26618866 | |
| Pubmed | 3.58e-04 | 655 | 33 | 5 | 35819319 | ||
| Pubmed | 3.74e-04 | 30 | 33 | 2 | 34905516 | ||
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | 4.82e-04 | 1082 | 33 | 6 | 38697112 | |
| Pubmed | 4.88e-04 | 162 | 33 | 3 | 25796446 | ||
| Pubmed | DNA Damage Regulates Translation through β-TRCP Targeting of CReP. | 5.09e-04 | 35 | 33 | 2 | 26091241 | |
| Pubmed | ARMC5 is part of an RPB1-specific ubiquitin ligase implicated in adrenal hyperplasia. | 5.24e-04 | 166 | 33 | 3 | 35687106 | |
| Pubmed | 5.39e-04 | 36 | 33 | 2 | 31669268 | ||
| Pubmed | 5.39e-04 | 36 | 33 | 2 | 24147044 | ||
| Pubmed | 5.78e-04 | 407 | 33 | 4 | 12693553 | ||
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | 6.08e-04 | 736 | 33 | 5 | 29676528 | |
| Pubmed | 6.39e-04 | 418 | 33 | 4 | 34709266 | ||
| Pubmed | An inducible CRISPR/Cas9 screen identifies DTX2 as a transcriptional regulator of human telomerase. | 6.64e-04 | 180 | 33 | 3 | 35198878 | |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | 7.10e-04 | 430 | 33 | 4 | 35044719 | |
| Pubmed | Interlaboratory reproducibility of large-scale human protein-complex analysis by standardized AP-MS. | 7.22e-04 | 432 | 33 | 4 | 23455922 | |
| Pubmed | 7.34e-04 | 42 | 33 | 2 | 34673265 | ||
| Pubmed | 7.34e-04 | 42 | 33 | 2 | 24997765 | ||
| Pubmed | 8.06e-04 | 44 | 33 | 2 | 31273033 | ||
| Pubmed | Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation. | 8.90e-04 | 457 | 33 | 4 | 32344865 | |
| Interaction | BTRC interactions | 2.95e-06 | 775 | 33 | 9 | int:BTRC | |
| Interaction | GLI3 interactions | 1.93e-05 | 98 | 33 | 4 | int:GLI3 | |
| Interaction | PI4KAP1 interactions | 2.53e-05 | 35 | 33 | 3 | int:PI4KAP1 | |
| Interaction | DDX24 interactions | 4.18e-05 | 596 | 33 | 7 | int:DDX24 | |
| Interaction | PRSS16 interactions | 5.06e-05 | 44 | 33 | 3 | int:PRSS16 | |
| Interaction | CYLD interactions | 6.09e-05 | 868 | 33 | 8 | int:CYLD | |
| Interaction | TJP2 interactions | 9.84e-05 | 288 | 33 | 5 | int:TJP2 | |
| Interaction | CFAP210 interactions | 1.16e-04 | 10 | 33 | 2 | int:CFAP210 | |
| Interaction | CNOT1 interactions | 1.29e-04 | 305 | 33 | 5 | int:CNOT1 | |
| Interaction | AMOT interactions | 1.43e-04 | 312 | 33 | 5 | int:AMOT | |
| Interaction | CEP85 interactions | 1.62e-04 | 169 | 33 | 4 | int:CEP85 | |
| Interaction | SAMD12 interactions | 2.01e-04 | 13 | 33 | 2 | int:SAMD12 | |
| Interaction | DSG1 interactions | 2.24e-04 | 184 | 33 | 4 | int:DSG1 | |
| Interaction | GPR18 interactions | 2.34e-04 | 14 | 33 | 2 | int:GPR18 | |
| Interaction | GPBP1 interactions | 2.49e-04 | 75 | 33 | 3 | int:GPBP1 | |
| Interaction | SH2D3A interactions | 2.49e-04 | 75 | 33 | 3 | int:SH2D3A | |
| Interaction | KLF5 interactions | 2.79e-04 | 195 | 33 | 4 | int:KLF5 | |
| Interaction | ARL16 interactions | 3.36e-04 | 83 | 33 | 3 | int:ARL16 | |
| Interaction | TLE3 interactions | 3.40e-04 | 376 | 33 | 5 | int:TLE3 | |
| Interaction | PTDSS1 interactions | 3.83e-04 | 212 | 33 | 4 | int:PTDSS1 | |
| Interaction | DPRX interactions | 3.91e-04 | 18 | 33 | 2 | int:DPRX | |
| Interaction | GTSE1 interactions | 4.04e-04 | 215 | 33 | 4 | int:GTSE1 | |
| Interaction | CFTR interactions | 4.65e-04 | 1480 | 33 | 9 | int:CFTR | |
| Interaction | RNF31 interactions | 4.67e-04 | 403 | 33 | 5 | int:RNF31 | |
| Interaction | NUP43 interactions | 4.71e-04 | 625 | 33 | 6 | int:NUP43 | |
| Interaction | MPHOSPH9 interactions | 5.00e-04 | 95 | 33 | 3 | int:MPHOSPH9 | |
| Interaction | CNOT9 interactions | 5.30e-04 | 231 | 33 | 4 | int:CNOT9 | |
| Interaction | FCF1 interactions | 5.47e-04 | 98 | 33 | 3 | int:FCF1 | |
| Interaction | KRT18 interactions | 5.57e-04 | 419 | 33 | 5 | int:KRT18 | |
| Interaction | ANXA2 interactions | 5.57e-04 | 419 | 33 | 5 | int:ANXA2 | |
| Interaction | DSP interactions | 5.82e-04 | 423 | 33 | 5 | int:DSP | |
| Interaction | RNF43 interactions | 6.07e-04 | 427 | 33 | 5 | int:RNF43 | |
| Interaction | ST6GALNAC6 interactions | 6.51e-04 | 104 | 33 | 3 | int:ST6GALNAC6 | |
| Interaction | CDC16 interactions | 6.71e-04 | 246 | 33 | 4 | int:CDC16 | |
| Interaction | LATS1 interactions | 6.95e-04 | 440 | 33 | 5 | int:LATS1 | |
| Interaction | KRT8 interactions | 7.02e-04 | 441 | 33 | 5 | int:KRT8 | |
| Interaction | KRT17 interactions | 7.34e-04 | 252 | 33 | 4 | int:KRT17 | |
| Cytoband | 1q21.3 | 1.55e-06 | 117 | 33 | 4 | 1q21.3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1q21 | 1.98e-04 | 404 | 33 | 4 | chr1q21 | |
| Cytoband | 1q32.1 | 2.76e-03 | 108 | 33 | 2 | 1q32.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr16p12 | 6.83e-03 | 172 | 33 | 2 | chr16p12 | |
| GeneFamily | EF-hand domain containing|S100 fused type protein family | 7.17e-08 | 7 | 24 | 3 | 1350 | |
| GeneFamily | Ataxins|Trinucleotide repeat containing | 4.97e-04 | 25 | 24 | 2 | 775 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 2.47e-03 | 206 | 24 | 3 | 682 | |
| GeneFamily | EF-hand domain containing | 2.94e-03 | 219 | 24 | 3 | 863 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 3.44e-03 | 66 | 24 | 2 | 722 | |
| GeneFamily | Fibronectin type III domain containing | 1.89e-02 | 160 | 24 | 2 | 555 | |
| CoexpressionAtlas | facebase_RNAseq_e14.5_palate_poster_proximal_ERK2_WT_2500_K1 | 7.37e-05 | 150 | 32 | 4 | facebase_RNAseq_e14.5_palate_poster_proximal_ERK2_WT_2500_K1 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_k-means-cluster#4_top-relative-expression-ranked_100 | 9.83e-05 | 10 | 32 | 2 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_100_k4 | |
| ToppCell | Control-Endothelial-Endothelial|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.97e-07 | 193 | 33 | 5 | aff0649c73c634bc6ff0dc7759b4693a9236bf05 | |
| ToppCell | Control-Endothelial|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.97e-07 | 193 | 33 | 5 | c5f9fe03e64c211d4bcd4959e5b32f14841e336a | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.29e-07 | 197 | 33 | 5 | c10dd1aaec01fb662eac83dfde90e3e426665d65 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Endothelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.29e-07 | 197 | 33 | 5 | 2844dbcd0a673ed81c99920aa45858651a00736d | |
| ToppCell | droplet-Liver-hepatocytes-3m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.67e-06 | 177 | 33 | 4 | 8ef41ee5d63737b810ad7371b0437625e7e1badf | |
| ToppCell | droplet-Spleen-nan-18m|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.67e-06 | 182 | 33 | 4 | eeb5dfa4539e9ca5220f26bc2b65717ddcf13b6c | |
| ToppCell | droplet-Spleen-nan-18m-Lymphocytic|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.88e-06 | 183 | 33 | 4 | 28cbf909424f3be4491d49832f0aca0386560814 | |
| ToppCell | Fetal_29-31_weeks-Endothelial-endothelial_cell_of_vein-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 9.88e-06 | 183 | 33 | 4 | c1297d8eddfc7132e84ceef14f01b6281f9d0f6a | |
| ToppCell | droplet-Spleen-nan-18m-Lymphocytic-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.88e-06 | 183 | 33 | 4 | 3fa608aa6b119869ec3280dc388dfee57160e63a | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Epithelial-Pecam____Kidney_cortex_artery_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.03e-05 | 185 | 33 | 4 | f98af3146ec2f44c30d31a662fb9c4fa3ca4f706 | |
| ToppCell | TCGA-Skin-Primary_Tumor-Melanoma-Skin_Cutaneous_Melanoma-6|TCGA-Skin / Sample_Type by Project: Shred V9 | 1.08e-05 | 187 | 33 | 4 | 2ca7928baf0c5e61f7294ed05e6e6f0e0adf9d3f | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum_-18m-Epithelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.12e-05 | 189 | 33 | 4 | 6f0fc5271a7d3682f145e734abc3be6473dda2e2 | |
| ToppCell | nucseq-Endothelial-Endothelial_Vascular-Endothelial_capillary-CAP2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.12e-05 | 189 | 33 | 4 | b6b4da51bc7f2c13a2f940540fdc61027d084835 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum_-18m-Epithelial-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.12e-05 | 189 | 33 | 4 | 3b9ce8964b16cb2200d30cbb0bfc711dcad2380e | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum_-18m-Epithelial-neuroepithelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.12e-05 | 189 | 33 | 4 | 38acb307907fde68b992057714448c1561d69ee3 | |
| ToppCell | droplet-Fat-BAT+GAT+MAT-30m-Endothelial-endothelial_cell|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.15e-05 | 190 | 33 | 4 | c8370c922e0cf0e0c36e02e1ed2b4053ad6a8073 | |
| ToppCell | TCGA-Skin-Primary_Tumor|TCGA-Skin / Sample_Type by Project: Shred V9 | 1.15e-05 | 190 | 33 | 4 | e2b26a03c6ab24d9b0f4150c47597be37767d86e | |
| ToppCell | droplet-Fat-BAT+GAT+MAT-30m-Endothelial-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.15e-05 | 190 | 33 | 4 | 5174f91a880f85bb20806023aa68bd4b8ca24ea5 | |
| ToppCell | TCGA-Skin-Primary_Tumor-Melanoma|TCGA-Skin / Sample_Type by Project: Shred V9 | 1.15e-05 | 190 | 33 | 4 | 01fb45add4661bc86cd0a34fac35177907152dbb | |
| ToppCell | TCGA-Skin-Primary_Tumor-Melanoma-Skin_Cutaneous_Melanoma|TCGA-Skin / Sample_Type by Project: Shred V9 | 1.15e-05 | 190 | 33 | 4 | 3188c7bd225cbcf46a21e2fb784336cdd9665995 | |
| ToppCell | Children_(3_yrs)-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.15e-05 | 190 | 33 | 4 | 0e9847d7f49b2236b8a191e1a7df37556351ba9e | |
| ToppCell | droplet-Fat-BAT+GAT+MAT-30m-Endothelial|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.15e-05 | 190 | 33 | 4 | 90e494cbfbed33a3a0d29bb7dae83f0c81580bcf | |
| ToppCell | Children_(3_yrs)-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.17e-05 | 191 | 33 | 4 | f229abf69a1217194f74b0502486907e07dba989 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Epithelial-Pecam____Kidney_cortex_artery_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.17e-05 | 191 | 33 | 4 | b9ae5af426e7a1f2652a47700bb168371bd2dec6 | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.19e-05 | 192 | 33 | 4 | c07d7b40b2aa4eb27ac85801c014a656e2fd01dc | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Endothelial-endothelial_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.19e-05 | 192 | 33 | 4 | bcd8876235be503186f119653b39476488c0fa15 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Endothelial|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.19e-05 | 192 | 33 | 4 | f4cd65e6c5b17bcabf45fe5b687246c72e7975f7 | |
| ToppCell | human_hepatoblastoma-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 1.19e-05 | 192 | 33 | 4 | 916fbec1c7ab7969bda711886ac88e877e30c280 | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.19e-05 | 192 | 33 | 4 | 04f5a2e3dd6beff027b89d66eefdd92036e041af | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.22e-05 | 193 | 33 | 4 | 826b8dd801298b3e0cd76232feae5a14026b8806 | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-Gen_Cap|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.22e-05 | 193 | 33 | 4 | e09387af84d2a0a526e54d4793e6e06c6739db53 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.22e-05 | 193 | 33 | 4 | 02f633b016ab19bfa65bfd0cf32f000549a62148 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Gen_Cap|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.22e-05 | 193 | 33 | 4 | 6e1982d089a9de628e6006d23ff78a223fbd9f47 | |
| ToppCell | human_hepatoblastoma|World / Sample and Cell Type and Tumor Cluster (all cells) | 1.22e-05 | 193 | 33 | 4 | e6a688bc834f845ff64dae1be64f073eec5091a1 | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.22e-05 | 193 | 33 | 4 | 87d3a577d37fb0cb4b6313c596310de452bc3872 | |
| ToppCell | Control-Endothelial-Endothelial-Gen_Cap|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.22e-05 | 193 | 33 | 4 | e1d546165dcc2392f540162206852c4717d7306f | |
| ToppCell | LPS-antiTNF-Endothelial|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.22e-05 | 193 | 33 | 4 | 5122b1ffba42de190061be34ecdc6176f84e56a3 | |
| ToppCell | COVID-19-Endothelial_cells-Inflamed_endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 1.22e-05 | 193 | 33 | 4 | 979ebefa527f86bebeea5d94e626ee6c1cc7d53b | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.22e-05 | 193 | 33 | 4 | d485634c564b268e344b6a2863c26f6adaec9e38 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Gen_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.24e-05 | 194 | 33 | 4 | 0b9cd96fa0b616da7cc90e92ff71157e9bba518f | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.24e-05 | 194 | 33 | 4 | 1d39d968730a7e85b6161c1c8a6bd38afe9bcad7 | |
| ToppCell | LPS-IL1RA-Endothelial|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.24e-05 | 194 | 33 | 4 | 43f92b0533e26633dc94cce554045d641ef8fd76 | |
| ToppCell | ASK454-Endothelial|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.29e-05 | 196 | 33 | 4 | 14dd6956ef420b660be0baf52a66960e57d75d16 | |
| ToppCell | ASK454-Endothelial-Endothelium|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.29e-05 | 196 | 33 | 4 | 2b777a2026b56839112fd179f2db482c49f4594a | |
| ToppCell | COVID-19-lung-Capillary_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.29e-05 | 196 | 33 | 4 | ac28e9be288af6f00a841aea4ce4b99aed6b4505 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.29e-05 | 196 | 33 | 4 | e224338490691d92c1f70b57112fabdcc92b06a9 | |
| ToppCell | COVID-19-lung-Capillary_1|lung / Disease (COVID-19 only), tissue and cell type | 1.32e-05 | 197 | 33 | 4 | 7e86ff9dafcbaaa7464d61484dd48bfeb7eae6e4 | |
| ToppCell | Skin|World / Skin and Kidney Cells in Lupus Nephritis Patients. | 1.37e-05 | 199 | 33 | 4 | 6be1340413ee868c610b6e3f58c65b493eb22bb5 | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 1.37e-05 | 199 | 33 | 4 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | 3'-Adult-LargeIntestine-Endothelial-blood_vessel_EC-Mature_arterial_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.37e-05 | 199 | 33 | 4 | 0075bcc7d2a5031e76a24cb176e16ac998d846fd | |
| ToppCell | Kidney-Keratinocytes|Kidney / Skin and Kidney Cells in Lupus Nephritis Patients. | 1.40e-05 | 200 | 33 | 4 | 41d83faa9f45ee7ea2ab19be8ecc6d2c5ac7fe5d | |
| ToppCell | TCGA-Bladder-Solid_Tissue_Normal-Urothelial_normal_tissue-Urothelial_normal_tissue-6|TCGA-Bladder / Sample_Type by Project: Shred V9 | 1.13e-04 | 127 | 33 | 3 | d61b71572eab8a850ee8ce54323fb247525006e5 | |
| ToppCell | facs-Limb_Muscle-forelimb_and_hindlimb-18m-Endothelial|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.41e-04 | 137 | 33 | 3 | b831d917f5073ccff158662adb281d34f023126a | |
| ToppCell | facs-Limb_Muscle-forelimb_and_hindlimb-18m-Endothelial-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.41e-04 | 137 | 33 | 3 | cf3e928d9a7a7349840bb87475a42a07f65b94f0 | |
| ToppCell | facs-Limb_Muscle-forelimb_and_hindlimb-18m-Endothelial-endothelial_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.41e-04 | 137 | 33 | 3 | 5d82d6c7eef4ec7a7fae60e37fb956488314987e | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L5_PT-L5_PT_VISp_Krt80|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.53e-04 | 141 | 33 | 3 | 40ef6d792e11fe10963d64eb0b606b90556c1a70 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Oligodendroglioma|TCGA-Brain / Sample_Type by Project: Shred V9 | 2.27e-04 | 161 | 33 | 3 | 5f6b2d7f80a8ee16651e304481d2da3fae313824 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L3_VIP_CBLN1|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.48e-04 | 166 | 33 | 3 | 688e3c01ffcec01eb7027df6f3bde8fecfb50479 | |
| ToppCell | Adult-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D231|Adult / Lineage, Cell type, age group and donor | 2.52e-04 | 167 | 33 | 3 | 5af9127bae05768a5164d5708a4ad37edca99324 | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_artery-D231|Adult / Lineage, Cell type, age group and donor | 2.57e-04 | 168 | 33 | 3 | aca34c51758c65925ad24110294a72b2dea6db72 | |
| ToppCell | TCGA-Bile_Duct-Primary_Tumor-Cholangiocarcinoma-Intrahepatic-2|TCGA-Bile_Duct / Sample_Type by Project: Shred V9 | 2.57e-04 | 168 | 33 | 3 | c70bf73bb800e4722cedc35bbc17ea3113d1012d | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_artery-D122|Adult / Lineage, Cell type, age group and donor | 2.57e-04 | 168 | 33 | 3 | 8c3e1e45b422813bcdfa4273b1167db649a312f5 | |
| ToppCell | droplet-Liver-LIVER_HEPATOCYTES-30m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.66e-04 | 170 | 33 | 3 | 50c6c571591aa4b218caefe5778c570c809f567e | |
| ToppCell | droplet-Liver-LIVER_HEPATOCYTES-30m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.66e-04 | 170 | 33 | 3 | 8fe32dcf924d5f6665f7febbc9647d96b1e96f06 | |
| ToppCell | droplet-Liver-LIVER_HEPATOCYTES-30m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.66e-04 | 170 | 33 | 3 | 3232db50b1a40f861e981a1b9c9073b81af9f832 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.71e-04 | 171 | 33 | 3 | 972fab891135bd755d5526cbc5a963200067b0a6 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.71e-04 | 171 | 33 | 3 | 2a77ed79c6f2e700e789c80451a70ecb31639719 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.75e-04 | 172 | 33 | 3 | 1ef243bce63d841c25e4b74d029d1377f84bcc3d | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.75e-04 | 172 | 33 | 3 | ab1c81be29f93ca8920c6ab5ab92f497a9256d3f | |
| ToppCell | PND07-Epithelial-Epithelial_Airway-Basal-Basal-Basal_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.80e-04 | 173 | 33 | 3 | 1b2508cc890430bd4b2cf232c633928edb86c57e | |
| ToppCell | wk_15-18-Mesenchymal-Fibroblast-Mesenchymal_3|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 2.80e-04 | 173 | 33 | 3 | b43817a6b1ed8d6b5366702343be4311c0d52d83 | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_vein-D231|Adult / Lineage, Cell type, age group and donor | 2.85e-04 | 174 | 33 | 3 | 2dd647c4fdf99fd1f7b838efef01baf2cbc3446d | |
| ToppCell | droplet-Mammary_Gland-nan-21m-Endothelial-basal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.95e-04 | 176 | 33 | 3 | 27e5115fae5f0f63b333bc99fbf6a6d4c9182c46 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.95e-04 | 176 | 33 | 3 | 9bc87cd5cda2372e1bce94c9dfd408eb1dfd8d0c | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.95e-04 | 176 | 33 | 3 | 3f8274a7ab67f9f8a8923193763a5543cfe4defa | |
| ToppCell | Fetal_29-31_weeks-Endothelial-endothelial_cell_of_artery|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.99e-04 | 177 | 33 | 3 | 5ff8dcfb030312126695d53a026d2e104a401b83 | |
| ToppCell | tumor_Lung-Endothelial_cells-EPCs|tumor_Lung / Location, Cell class and cell subclass | 2.99e-04 | 177 | 33 | 3 | f8b152c09d56a97e8c0482fb1a3964c05f9dc8c5 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma|TCGA-Brain / Sample_Type by Project: Shred V9 | 2.99e-04 | 177 | 33 | 3 | e8ab340b20cd41554c3841fe980e078e878af35f | |
| ToppCell | 367C-Endothelial_cells-Endothelial-B_(Artery)|367C / Donor, Lineage, Cell class and subclass (all cells) | 3.04e-04 | 178 | 33 | 3 | e1e96a0e3ff718ebf676a982bc63e8ced6984059 | |
| ToppCell | wk_20-22-Epithelial-Proximal_epithelial-basal_late|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 3.04e-04 | 178 | 33 | 3 | 03f22485074b3cbf9a6ad4d543c5bbfa826dc741 | |
| ToppCell | 367C-Endothelial_cells-Endothelial-B_(Artery)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 3.04e-04 | 178 | 33 | 3 | 363e8b23b3834692a8a79e5fdc7b43bd3a4dab5e | |
| ToppCell | TCGA-Adrenal-Primary_Tumor-Pheochromocytoma-Pheochromocytoma-1|TCGA-Adrenal / Sample_Type by Project: Shred V9 | 3.09e-04 | 179 | 33 | 3 | 431e1b29015ec817f778499106d24b19cfc825ae | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.09e-04 | 179 | 33 | 3 | 02c90d8306016365ed811f0c63cfb3ac7b85464c | |
| ToppCell | 10x3'2.3-week_12-13-Myeloid_macrophage-stroma-erythroid_macrophage|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 3.09e-04 | 179 | 33 | 3 | c17ae394b855f01f8ca1765c416fd8b34a96e60b | |
| ToppCell | COVID-19-kidney-PLVAP+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.15e-04 | 180 | 33 | 3 | 493cf8d1a8f2a1ed2672f394a0338b110fd81d88 | |
| ToppCell | Control-Endothelial_cells-Capillary_endothelial_cells|Control / group, cell type (main and fine annotations) | 3.15e-04 | 180 | 33 | 3 | b043f9ffb9a4cd427a15bebb86a711c7b08866e8 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus_-18m-Epithelial-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.20e-04 | 181 | 33 | 3 | a5e770b5b5d57cbac18560828e89f7c96b687743 | |
| ToppCell | COVID-19-Endothelial_cells-Capillary_endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 3.20e-04 | 181 | 33 | 3 | c5f9c92af1384d9089c65afdf41c6feb8345a3ae | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Epithelial-neuronal_stem_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.20e-04 | 181 | 33 | 3 | 4e81ec1580e9acb22c32c465eb46f83d1e9e424e | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Epithelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.20e-04 | 181 | 33 | 3 | ad30c01290fb98adbd0caed301a584761212c977 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Epithelial-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.20e-04 | 181 | 33 | 3 | 3a3268a4dff8ffcb79e09f46490e138c96f8d916 | |
| ToppCell | droplet-Liver-hepatocytes-3m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.20e-04 | 181 | 33 | 3 | 4df7972f88117108698efd06b124b232f8588981 | |
| ToppCell | PND07-Epithelial-Epithelial_Airway-Basal-Basal|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.20e-04 | 181 | 33 | 3 | 6b43dcaeeb02ad5900772b6f16f1581847050e38 | |
| ToppCell | PND10-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.20e-04 | 181 | 33 | 3 | 4d7793026373cbcf04b15c77f95f1025d07d4c00 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus_-18m-Epithelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.20e-04 | 181 | 33 | 3 | 504b1af1951a7a20ef5db69d84c20630ec64095b | |
| ToppCell | PND07-Epithelial-Epithelial_Airway-Basal|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.20e-04 | 181 | 33 | 3 | f50561fdacfb83ba85fe6476e7cbc2bad1ebc826 | |
| ToppCell | droplet-Liver-hepatocytes-3m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.20e-04 | 181 | 33 | 3 | cbb530566893281289026bfd93adf721decd4ca3 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus_-18m-Epithelial-neuroepithelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.20e-04 | 181 | 33 | 3 | a55ec36d2393f7a376feb42b22aee75dfdf4c383 | |
| ToppCell | Children_(3_yrs)-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.25e-04 | 182 | 33 | 3 | a20017b6a4f9a6a29e090e4dbd7c02ed1495bd50 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.25e-04 | 182 | 33 | 3 | 44764676ed3f51ba171ce63f669390392fa50a43 | |
| Drug | STOCK1N-35215; Down 200; 10uM; PC3; HT_HG-U133A | 3.14e-07 | 193 | 33 | 6 | 6427_DN | |
| Drug | F0447-0125; Down 200; 10uM; PC3; HT_HG-U133A | 6.45e-06 | 184 | 33 | 5 | 6429_DN | |
| Disease | aortic measurement | 1.52e-04 | 251 | 32 | 4 | EFO_0020865 | |
| Disease | Antihypertensive use measurement | 1.88e-04 | 265 | 32 | 4 | EFO_0009927 | |
| Disease | Drug Use Disorders | 2.63e-04 | 115 | 32 | 3 | C0013222 | |
| Disease | Drug Dependence | 2.63e-04 | 115 | 32 | 3 | C1510472 | |
| Disease | Drug habituation | 2.63e-04 | 115 | 32 | 3 | C0013170 | |
| Disease | Substance Dependence | 2.63e-04 | 115 | 32 | 3 | C0038580 | |
| Disease | Substance Use Disorders | 2.63e-04 | 115 | 32 | 3 | C0038586 | |
| Disease | Substance-Related Disorders | 2.63e-04 | 115 | 32 | 3 | C0236969 | |
| Disease | Drug abuse | 2.63e-04 | 115 | 32 | 3 | C0013146 | |
| Disease | Organic Mental Disorders, Substance-Induced | 2.63e-04 | 115 | 32 | 3 | C0029231 | |
| Disease | Prescription Drug Abuse | 2.63e-04 | 115 | 32 | 3 | C4316881 | |
| Disease | Substance abuse problem | 2.70e-04 | 116 | 32 | 3 | C0740858 | |
| Disease | ascending aortic diameter | 4.69e-04 | 140 | 32 | 3 | EFO_0021787 | |
| Disease | neurodegenerative disease (implicated_via_orthology) | 5.19e-04 | 145 | 32 | 3 | DOID:1289 (implicated_via_orthology) | |
| Disease | glucose metabolism measurement, age-related hearing impairment | 1.46e-03 | 52 | 32 | 2 | EFO_0005782, EFO_0009367 | |
| Disease | alcohol use disorder measurement | 1.60e-03 | 214 | 32 | 3 | EFO_0009458 | |
| Disease | waist-hip ratio | 1.82e-03 | 1226 | 32 | 6 | EFO_0004343 | |
| Disease | polycystic ovary syndrome | 1.94e-03 | 60 | 32 | 2 | EFO_0000660 | |
| Disease | mean arterial pressure | 2.00e-03 | 499 | 32 | 4 | EFO_0006340 | |
| Disease | carcinoma (implicated_via_orthology) | 2.20e-03 | 64 | 32 | 2 | DOID:305 (implicated_via_orthology) | |
| Disease | pulse pressure measurement, alcohol drinking | 2.63e-03 | 70 | 32 | 2 | EFO_0004329, EFO_0005763 | |
| Disease | axial length measurement | 3.17e-03 | 77 | 32 | 2 | EFO_0005318 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| RHAYEGSSSGNSSPE | 106 | Q9UMD9 | |
| RGFSAPYQGSSTLTH | 336 | Q7Z407 | |
| SFHSRTSGKSNRNGP | 151 | Q9UIF8 | |
| GPNSELHYSLSGRNS | 2496 | Q6V0I7 | |
| PSYGQGLRTSSLSHS | 4676 | Q6V0I7 | |
| QSAPSTGGRQGSHYD | 2106 | P20930 | |
| QDSAYHSGIQSRGSP | 3936 | P20930 | |
| RYQNHSSKSSGRSGR | 96 | P49759 | |
| SRSRQSSYGQHGSGS | 536 | Q5D862 | |
| PSYSSHQQSRGGADS | 296 | Q9P266 | |
| SSGSFSQRNHLPSSG | 591 | Q6ZNL6 | |
| RQGSSAGSSSSYGQH | 506 | Q86YZ3 | |
| GRHESGSRQSSSYGP | 546 | Q86YZ3 | |
| GRSSSRGPYESRSGH | 1266 | Q86YZ3 | |
| SSRYGQHGSGSRQSS | 1686 | Q86YZ3 | |
| GRSSSRGPYESRSGH | 1736 | Q86YZ3 | |
| SSRYGQHGSGSRQSS | 2156 | Q86YZ3 | |
| GRSSSRGPYESRSGH | 2206 | Q86YZ3 | |
| RPQRYSSGHGSDNSS | 1621 | Q9ULI4 | |
| LGAGRPHNASSADSY | 841 | P10070 | |
| IYSSHNQPSTGGRTT | 531 | Q8WVV4 | |
| PSGSVHSFSNGRAGY | 211 | Q8TBM8 | |
| YSRHGGVNSSSPNTG | 336 | Q5SQI0 | |
| NHRESENSGDSGYPS | 431 | O00418 | |
| TSDGFNHPARSSGQS | 6 | Q92681 | |
| SRYSRPQAHSSASGG | 396 | Q08AD1 | |
| GGSGYHSRSPARQES | 1816 | Q9UQ35 | |
| NSYGSHRTLQRLSSG | 301 | Q9Y446 | |
| HRGGLGPSATYSSNS | 676 | Q9Y2H5 | |
| SRGVAYSTHRTNAPG | 86 | Q8IVF5 | |
| SGGRNSSSNSYGQSH | 401 | Q8N7X1 | |
| GGRSPDTYSRGHDSS | 721 | Q8N7X1 | |
| PNAYSGGHNSSSRND | 796 | Q8N7X1 | |
| GDHDRSSNSYGRSDR | 996 | Q8N7X1 | |
| NGTAGDSLSYHQGRP | 1261 | Q92752 | |
| RGHSSYSPSNTARLG | 2296 | Q96JG9 | |
| SPQSHRAAGSGVSDY | 46 | Q9C026 | |
| NYSSNSSLEHRGPNS | 666 | Q9ULT6 | |
| SGGHGPLRYRSSSST | 1106 | Q8N1G0 | |
| SQGASSARHGYSSPA | 201 | Q6ZMP0 | |
| GGDHPSFTSGTRNYR | 286 | Q5VUA4 | |
| STSGSHYENSQRGPV | 201 | Q8NDV7 | |
| GSSDSHNSGRRSYRP | 581 | Q9UPQ9 | |
| NGGPYHSREQSTDSG | 301 | Q9GZV5 |